Emyria Ltd passes MDMA analogue development milestone with Eurofins to lead extensive compound screening program
“We are pleased to be working with global leader Eurofins to screen our first batch of novel MDMA-analogues after successfully completing...
Matt Piggott Michael Winlo Palantir Foundry Builders Program Therapeutic Goods Administration University Of Western Australia Western Australia
Source: proactiveinvestors.com.au